市場調查報告書

人體生長荷爾蒙的全球市場:各用途、給藥途徑、流通管道 - 機會分析,及產業預測(2019年∼2026年)

Human Growth Hormone Market by Application, Route of Administration, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2019-2026

出版商 Allied Market Research 商品編碼 920148
出版日期 內容資訊 英文 212 Pages
商品交期: 2-3個工作天內
價格
人體生長荷爾蒙的全球市場:各用途、給藥途徑、流通管道 - 機會分析,及產業預測(2019年∼2026年) Human Growth Hormone Market by Application, Route of Administration, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2019-2026
出版日期: 2019年11月13日內容資訊: 英文 212 Pages
簡介

全球人體生長荷爾蒙市場在2018年估算為28億4,070萬美金。該市場在2019年∼2026年間,預測將以8.6%的年複合成長率成長,2026年達到55億6,360萬美元的規模。

本報告提供全球人體生長荷爾蒙市場的相關調查,市場機會,成長及阻礙因素,各用途、給藥途徑、流通管道、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 報告的說明
  • 利害關係者的主要優點
  • 調查方法
    • 二次調查
    • 一次調查
    • 分析師的工具、模式

第2章 摘要整理

  • Cxo的見解

第3章 市場概要

  • 市場定義、範圍
  • 波特的五力分析
  • 主要企業的地位
  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會

第4章 市場分析:各用途

  • 概要
    • 市場規模、預測
  • 生長激素缺乏症
    • 主要市場趨勢、機會
    • 市場規模、預測:各地區
    • 市場分析:各國
  • 普拉達、威利症候群
  • 透納氏症
  • 胎兒小於妊娠年齡(Sga)
  • 其他

第5章 市場分析:各給藥途徑

  • 概要
    • 市場規模、預測
  • 口服
    • 市場規模、預測:各地區
    • 市場分析:各國
  • 靜脈內
  • 肌肉內
  • 皮下

第6章 市場分析:各流通管道

  • 概要
    • 市場規模、預測
  • 醫院藥局
    • 市場規模、預測:各地區
    • 市場分析:各國
  • 零售藥局
  • 線上藥局

第7章 市場分析:各地區

  • 概要
    • 市場規模、預測
  • 北美
    • 主要市場趨勢、機會
    • 各用途
    • 各給藥途徑
    • 流通管道
  • 歐洲
  • 亞太地區
  • 南美、中東、非洲

第8章 企業簡介

  • Novo Nordisk
    • 企業概要
    • 企業概況
    • 業務部門
    • 產品系列
    • 業績
  • Merck & Co.
  • Eli Lilly And Company.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries.
  • Novartis Ag
  • Anhui Anke Biotechnology (Group) Co., Ltd.
  • Roche
  • Ipsen
  • Ferring Bv
目錄
Product Code: LI_195557

The global human growth hormone market was valued at $2,840.70 million in 2018 and is expected to reach $5,563.60 million by 2026, registering a CAGR of 8.6% from 2019 to 2026. Human growth hormone is a protein made by the pituitary gland and is secreted into the bloodstream to other parts of the body. Its production is regulated by an intricate set of hormones produced in the hypothalamus gland, intestinal tract, and pancreas. Further, these hormones act on several tissues throughout the body. In adolescents, it stimulates the growth of bone and cartilage. Whereas in adults, it boosts protein production, promotes the utilization of fat, interferes with the action of insulin, and raises blood sugar levels. GH also raises levels of insulin-like growth factor1.

Surge in awareness regarding the effectiveness of growth hormones and increase in prevalence of chronic diseases including growth retardation and pituitary dysfunctions and surge in compliance for growth hormone formulations are the major factors that drive the growth of the global human growth hormone market. However, the side effects associated with its vigorous usage such as muscle pain, joint pain, and fluid retention and high cost of the treatment hampers the growth of the market. Moreover, stringent government approvals are expected to restrain the growth and development of the market in the coming years. Furthermore, rise in disposable income and surge in healthcare expenditure in developing economies is anticipated to create lucrative growth opportunities for the market.

The human growth hormone market can be segmented on the basis of application, route of administration, distribution channel, and region. By application, it is categorized into growth hormone deficiency, Prader-Willi syndrome, Turner syndrome, and small for gestational age, and others . By route of administration, it is classified into intravenous, intramuscular, subcutaneous, and oral. On the basis of distribution channel, it is divided into hospital pharmacy, retail pharmacy, clinic, and online pharmacy. Region wise, it is analyzed across North America, Asia-Pacific, Europe, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Application

  • Growth Hormone Deficiency
  • Prader-Willi Syndrome
  • Turner Syndrome
  • Small for Gestational Age
  • Others

By Route of Administration

  • Intravenous
  • Intramuscular
  • Subcutaneous
  • Oral

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Clinics
  • Online Pharmacy

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
  • LIST OF KEY PLAYERS
  • Novo Nordisk
  • Merck & Co., Inc
  • Eli Lilly and Company
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd
  • Novartis AG
  • AnkeBio Co. Ltd
  • F. Hoffmann-La Roche
  • Ipsen
  • Ferring B.V.

Table of Contents

Chapter 1: Introduction

  • 1.1. Report Description
  • 1.2. Key Benefits For Stakeholders
  • 1.3. Research Methodology
    • 1.3.1. Secondary Research
    • 1.3.2. Primary Research
    • 1.3.3. Analyst Tools & Models

Chapter 2: Executive Summary

  • 2.1. Cxo Perspective

Chapter 3: Market Overview

  • 3.1. Market Definition And Scope
  • 3.2. Porter'S Five Forces Analysis
  • 3.3. Top Player Positioning
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase In Usage Of Growth Hormone To Control Aging
      • 3.4.1.2. Surge In Disorders Related To Growth Hormone Deficiency
    • 3.4.2. Restraints
      • 3.4.2.1. Side Effects Associated With The Treatment
    • 3.4.3. Opportunities
      • 3.4.3.1. Rise In Awareness Towards Usage Of Human Growth In Developing Economies

Chapter 4: Human Growth Hormone Market, By Application

  • 4.1. Overview
    • 4.1.1. Market Size And Forecast, By Application
  • 4.2. Growth Hormone Deficiency
    • 4.2.1. Key Market Trends And Opportunities
    • 4.2.2. Market Size And Forecast, By Region
    • 4.2.3. Market Analysis, By Country
  • 4.3. Prader-Willi Syndrome
    • 4.3.1. Key Market Trends And Opportunities
    • 4.3.2. Market Size And Forecast, By Region
    • 4.3.3. Market Analysis, By Country
  • 4.4. Turner Syndrome
    • 4.4.1. Key Market Trends And Opportunities
    • 4.4.2. Market Size And Forecast, By Region
    • 4.4.3. Market Analysis, By Country
  • 4.5. Small For Gestational Age (Sga)
    • 4.5.1. Key Market Trends And Opportunities
    • 4.5.2. Market Size And Forecast, By Region
    • 4.5.3. Market Analysis, By Country
  • 4.6. Others
    • 4.6.1. Key Market Trends And Opportunities
    • 4.6.2. Market Size And Forecast, By Region
    • 4.6.3. Market Analysis, By Country

Chapter 5: Human Growth Hormone Market, By Route Of Administration

  • 5.1. Overview
    • 5.1.1. Market Size And Forecast, By Application
  • 5.2. Oral
    • 5.2.1. Market Size And Forecast, By Region
    • 5.2.2. Market Analysis, By Country
  • 5.3. Intravenous
    • 5.3.1. Market Size And Forecast, By Region
    • 5.3.2. Market Analysis, By Country
  • 5.4. Intramuscular
    • 5.4.1. Market Size And Forecast, By Region
    • 5.4.2. Market Analysis, By Country
  • 5.5. Subcutaneous
    • 5.5.1. Market Size And Forecast, By Region
    • 5.5.2. Market Analysis, By Country

Chapter 6: Human Growth Hormone Market, Distribution Channel

  • 6.1. Overview
    • 6.1.1. Market Size And Forecast, Distribution Channel
  • 6.2. Hospital Pharmacy
    • 6.2.1. Market Size And Forecast, By Region
    • 6.2.2. Market Analysis, By Country
  • 6.3. Retail Pharmacy
    • 6.3.1. Market Size And Forecast, By Region
    • 6.3.2. Market Analysis, By Country
  • 6.4. Online Pharmacy
    • 6.4.1. Market Size And Forecast, By Region
    • 6.4.2. Market Analysis, By Country

Chapter 7: Human Growth Hormone Market, By Region

  • 7.1. Overview
    • 7.1.1. Market Size And Forecast
  • 7.2. North America
    • 7.2.1. Key Market Trends And Opportunities
    • 7.2.2. Market Size And Forecast, By Application
    • 7.2.3. Market Size And Forecast, By Route Of Administration
    • 7.2.4. Market Size And Forecast, Distribution Channel
      • 7.2.4.1. U.S. Market Size And Forecast, By Application
      • 7.2.4.2. U.S. Market Size And Forecast, By Route Of Administration
      • 7.2.4.3. U.S. Market Size And Forecast, Distribution Channel
      • 7.2.4.4. Canada Market Size And Forecast, By Application
      • 7.2.4.5. Canada Market Size And Forecast, By Route Of Administration
      • 7.2.4.6. Canada Market Size And Forecast, Distribution Channel
      • 7.2.4.7. Mexico Market Size And Forecast, By Application
      • 7.2.4.8. Mexico Market Size And Forecast, By Route Of Administration
      • 7.2.4.9. Mexico Market Size And Forecast, Distribution Channel
  • 7.3. Europe
    • 7.3.1. Key Market Trends And Opportunities
    • 7.3.2. Europe Market Size And Forecast, By Application
    • 7.3.3. Europe Market Size And Forecast, By Route Of Administration
    • 7.3.4. Europe Market Size And Forecast, Distribution Channel
    • 7.3.5. Europe Market Size And Forecast, By Country
      • 7.3.5.1. France Market Size And Forecast, By Application
      • 7.3.5.2. France Market Size And Forecast, By Route Of Administration
      • 7.3.5.3. France Market Size And Forecast, Distribution Channel
      • 7.3.5.4. Uk Market Size And Forecast, By Application
      • 7.3.5.5. Uk Market Size And Forecast, By Route Of Administration
      • 7.3.5.6. Uk Market Size And Forecast, Distribution Channel
      • 7.3.5.7. Germany Market Size And Forecast, By Application
      • 7.3.5.8. Germany Market Size And Forecast, By Route Of Administration
      • 7.3.5.9. Germany Market Size And Forecast, Distribution Channel
      • 7.3.5.10. Spain Market Size And Forecast, By Application
      • 7.3.5.11. Spain Market Size And Forecast, By Route Of Administration
      • 7.3.5.12. Spain Market Size And Forecast, Distribution Channel
      • 7.3.5.13. Rest Of Europe Market Size And Forecast, By Application
      • 7.3.5.14. Rest Of Europe Market Size And Forecast, By Route Of Administration
      • 7.3.5.15. Rest Of Europe Market Size And Forecast, Distribution Channel
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends And Opportunities
    • 7.4.2. Asia-Pacific Market Size And Forecast, By Application
    • 7.4.3. Asia-Pacific Market Size And Forecast, By Route Of Administration
    • 7.4.4. Asia-Pacific Market Size And Forecast, Distribution Channel
    • 7.4.5. Asia-Pacific Market Size And Forecast, By Country
      • 7.4.5.1. Japan Market Size And Forecast, By Application
      • 7.4.5.2. Japan Market Size And Forecast, By Route Of Administration
      • 7.4.5.3. Japan Market Size And Forecast, Distribution Channel
      • 7.4.5.4. China Market Size And Forecast, By Application
      • 7.4.5.5. China Market Size And Forecast, By Route Of Administration
      • 7.4.5.6. China Market Size And Forecast, Distribution Channel
      • 7.4.5.7. India Market Size And Forecast, By Application
      • 7.4.5.8. India Market Size And Forecast, By Route Of Administration
      • 7.4.5.9. India Market Size And Forecast, Distribution Channel
      • 7.4.5.10. Australia Market Size And Forecast, By Application
      • 7.4.5.11. Australia Market Size And Forecast, By Application
      • 7.4.5.12. Australia Market Size And Forecast, Distribution Channel
      • 7.4.5.13. Rest Of Asia-Pacific Market Size And Forecast, By Application
      • 7.4.5.14. Rest Of Asia-Pacific Market Size And Forecast, By Route Of Administration
      • 7.4.5.15. Rest Of Asia-Pacific Market Size And Forecast, Distribution Channel
  • 7.5. Lamea
    • 7.5.1. Key Market Trends And Opportunities
    • 7.5.2. Lamea Market Size And Forecast, By Application
    • 7.5.3. Lamea Market Size And Forecast, By Route Of Administration
    • 7.5.4. Lamea Market Size And Forecast, Distribution Channel
    • 7.5.5. Lamea Market Size And Forecast, By Country
      • 7.5.5.1. Brazil Market Size And Forecast, By Application
      • 7.5.5.2. Brazil Market Size And Forecast, By Route Of Administration
      • 7.5.5.3. Brazil Market Size And Forecast, Distribution Channel
      • 7.5.5.4. Saudi Arabia Market Size And Forecast, By Application
      • 7.5.5.5. Saudi Arabia Market Size And Forecast, By Route Of Administration
      • 7.5.5.6. Saudi Arabia Market Size And Forecast, Distribution Channel
      • 7.5.5.7. South Africa Market Size And Forecast, By Application
      • 7.5.5.8. South Africa Market Size And Forecast, By Route Of Administration
      • 7.5.5.9. South Africa Market Size And Forecast, Distribution Channel
      • 7.5.5.11. Rest Of Lamea Market Size And Forecast, By Application
      • 7.5.5.12. Rest Of Lamea Market Size And Forecast, By Route Of Administration
      • 7.5.5.13. Rest Of Lamea Market Size And Forecast, Distribution Channel

Chapter 8: Company Profiles

  • 8.1. Novo Nordisk
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Operating Business Segments
    • 8.1.4. Product Portfolio
    • 8.1.5. Business Performance
  • 8.2. Merck & Co.
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Operating Business Segments
    • 8.2.4. Product Portfolio
    • 8.2.5. Business Performance
  • 8.3. Eli Lilly And Company.
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Operating Business Segments
    • 8.3.4. Product Portfolio
    • 8.3.5. Business Performance
  • 8.4. Pfizer Inc.
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Operating Business Segments
    • 8.4.4. Product Portfolio
    • 8.4.5. Business Performance
  • 8.5. Teva Pharmaceutical Industries.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Operating Business Segments
    • 8.5.4. Product Portfolio
    • 8.5.5. Business Performance
  • 8.6. Novartis Ag
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Operating Business Segments
    • 8.6.4. Product Portfolio
    • 8.6.5. Business Performance
  • 8.7. Anhui Anke Biotechnology (Group) Co., Ltd.
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Operating Business Segments
    • 8.7.4. Product Portfolio
  • 8.8. Roche
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Operating Business Segments
    • 8.8.4. Product Portfolio
    • 8.8.5. Business Performance
  • 8.9. Ipsen
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Operating Business Segments
    • 8.9.4. Product Portfolio
    • 8.9.5. Business Performance
  • 8.10. Ferring Bv
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Operating Business Segments
    • 8.10.4. Product Portfolio
    • 8.10.5. Business Performance

List of Tables

List of Tables

Table 01. Global Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 02. Growth Hormone Deficiency Market, By Region, 2018-2026 ($Million)

Table 03. Comparative Share Analysis of Human Growth Hormone Market For Growth Hormone Deficiency, By Country, 2018 & 2026 (%)

Table 04. Prader-Willi Syndrome Market By Region 2018-2026 ($Million)

Table 05. Comparative Share Analysis of Human Growth Hormone Market For Prader Willi, By Country, 2018 & 2026 (%)

Table 06. Turner Syndrome Market By Region 2018-2026 ($Million)

Table 07. Comparative Share Analysis of Human Growth Hormone Market For Turner Syndrome, By Country, 2018 & 2026 (%)

Table 08. Human Growth Hormone Market For Small For Gestational Age (Sga) Market By Region 2018-2026 ($Million)

Table 09. Comparative Share Analysis of Human Growth Hormone Market For Sgh, By Country, 2018 & 2026 (%)

Table 10. Human Growth Hormone Market For Other Applications By Region 2018-2026 ($Million)

Table 11. Comparative Share Analysis of Human Growth Hormone Market For Other Applications, By Country, 2018 & 2026 (%)

Table 12. Global Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 13. Oral Route of Adminstration By Region, 2018-2026 ($Million)

Table 14. Comparative Share Analysis of Human Growth Hormone Market For Oral, By Country, 2018 & 2026 (%)

Table 15. Intravenous Route of Administration Market By Region 2018-2026 ($Million)

Table 16. Comparative Share Analysis of Human Growth Hormone Market For Intravenous, By Country, 2018 & 2026 (%)

Table 17. Intramuscular Route of Administration Market By Region 2018-2026 ($Million)

Table 18. Comparative Share Analysis of Human Growth Hormone Market For Intramuscular, By Country, 2018 & 2026 (%)

Table 19. Subcutaneous Route of Administration Market By Region 2018-2026 ($Million)

Table 20. Comparative Share Analysis of Human Growth Hormone Market For Subcutaneous, By Country, 2018 & 2026 (%)

Table 21. Global Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 22. Hospital Pharmacy Human Growth Hormone Market, By Region, 2018-2026 ($Million)

Table 23. Retail Pharmacy Human Growth Hormone Market, By Region, 2018-2026 ($Million)

Table 24. Online Pharmacy Human Growth Hormone Market, By Region, 2018-2026 ($Million)

Table 25. Human Growth Hormone Market, By Region, 2018-2026 ($Million)

Table 26. North America Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 27. North America Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 28. North America Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 29. U.S. Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 30. U.S. Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 31. U.S. Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 32. Canada Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 33. Canada Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 34. Canada Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 35. Mexico Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 36. Mexico Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 37. Mexico Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 38. Europe Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 39. Europe Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 40. Europe Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 41. Europe Human Growth Hormone Market, By Country, 2018-2026 ($Million)

Table 42. France Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 43. France Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 44. France Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 45. Uk Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 46. Uk Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 47. Uk Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 48. Germany Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 49. Germany Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 50. Germany Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 51. Spain Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 52. Spain Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 53. Spain Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 54. Rest of Europe Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 55. Rest of Europe Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 56. Rest of Europe Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 57. Asia-Pacific Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 58. Asia-Pacific Human Growth Hormone Market, By Administration, 2018-2026 ($Million)

Table 59. Asia-Pacific Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 60. Asia-Pacific Human Growth Hormone Market, By Country, 2018-2026 ($Million)

Table 61. Japan Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 62. Japan Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 63. Japan Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 64. China Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 65. China Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 66. China Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 67. India Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 68. India Human Growth Hormone Market, By Administration, 2018-2026 ($Million)

Table 69. India Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 70. Australia Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 71. Australia Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 72. Australia Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 73. Rest of Asia-Pacific Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 74. Rest of Asia-Pacific Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 75. Rest of Asia-Pacific Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 76. Lamea Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 77. Lamea Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 78. Lamea Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 79. Lamea Human Growth Hormone Market, By Country, 2018-2026 ($Million)

Table 80. Brazil Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 81. Brazil Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 82. Brazil Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 83. Saudi Arabia Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 84. Saudi Arabia Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 85. Saudi Arabia Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 86. South Africa Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 87. South Africa Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 88. South Africa Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 89. Rest of Lamea Human Growth Hormone Market, By Application, 2018-2026 ($Million)

Table 90. Rest of Lamea Human Growth Hormone Market, By Route of Administration, 2018-2026 ($Million)

Table 91. Rest of Lamea Human Growth Hormone Market, Distribution Channel, 2018-2026 ($Million)

Table 92. Novo Nordisk: Company Snapshot

Table 93. Novo Nordisk: Operating Segments

Table 94. Novo Nordisk Plc: Product Portfolio

Table 95. Merck & Co.: Company Snapshot

Table 96. Merck & Co. Inc.: Operating Segments

Table 97. Merck & Co. Inc.: Product Portfolio

Table 98. Eli Lilly And Company.: Company Snapshot

Table 99. Eli Lilly And Company.: Operating Segments

Table 100. Eli Lilly And Company.: Product Portfolio:

  • Table 101. Pfizer Inc.: Company Snapshot
  • Table 102. Pfizer Inc.: Operating Segments
  • Table 103. Pfizer Inc.: Product Portfolio
  • Table 104. Teva Pharmaceutical Industries.: Company Snapshot
  • Table 105. Teva Pharmaceutical Industries.: Operating Segments
  • Table 106. Teva Pharmaceutical Industries.: Product Portfolio
  • Table 107. Novartis Ag: Company Snapshot
  • Table 108. Novartis Ag: Operating Segments
  • Table 109. Novartis Ag: Product Portfolio
  • Table 110. Anhui Anke Biotechnology (Group) Co., Ltd.: Company Snapshot
  • Table 111. Anhui Anke Biotechnology (Group) Co., Ltd.: Operating Segments
  • Table 112. Anhui Anke Biotechnology (Group) Co., Ltd: Product Portfolio
  • Table 113. Roche: Company Snapshot
  • Table 114. Roche: Operating Segments
  • Table 115. Roche: Product Portfolio
  • Table 116. Ipsen: Company Snapshot
  • Table 117. Ipsen: Product Segments
  • Table 118. Ipsen: Product Portfolio
  • Table 119. Ferring Bv.: Company Snapshot
  • Table 120. Ferring Bv.: Operating Segments
  • Table 121. Ferring Bv: Product Portfolio

List of Figures

List of Figures

Figure 01. Global Human Growth Hormone Market Segmentation

Figure 02. Low-To- Moderate Bargaining Power of Supplier

Figure 03. Moderate Bargaining Power of Buyer

Figure 04. Moderate Threat of Substitutes

Figure 05. Low-To-Moderate Threat of New Entrants

Figure 06. Low Competitive Rivalary

Figure 07. Top Player Positioning, 2018

Figure 08. Drivers And Restraints

Figure 09. Comparative Share Analysis of Human Growth Hormone Market, For Hospitals, By Country, 2018 & 2026 (%)

Figure 10. Comparative Share Analysis of Human Growth Hormone Market For Retail Pharmacy, By Country, 2018 & 2026 (%)

Figure 11. Comparative Share Analysis of Human Growth Hormone Market For Online Pharmacy, By Country, 2018 & 2026 (%)

Figure 12. Novo Nordisk: Revenue Share By Segment, 2018 (%)

Figure 13. Novo Nordisk: Revenue Share By Geography, 2018 (%)

Figure 14. Merck & Co.: Net Sales, 2016-2018 ($Million)

Figure 15. Merck & Co.: Revenue Share By Segment, 2018 (%)

Figure 16. Merck & Co.: Revenue Share By Region, 2018(%)

Figure 17. Eli Lilly And Company: Net Sales, 2016-2018 ($Million)

Figure 18. Eli Lilly And Company: Revenue Share By Region, 2018(%)

Figure 19. Eli Lilly And Company: Revenue Share By Segment, 2018 (%)

Figure 20. Pfizer: Net Sales, 2016-2018 ($Million)

Figure 21. Pfizer.: Revenue Share By Segment, 2018 (%)

Figure 01. Pfizer Inc: Revenue Share By Region, 2018(%)

Figure 02. Teva Pharmaceutical Industries.: Net Sales, 2016-2018 ($Million)

Figure 03. Teva Pharmaceutical Industries.: Revenue Share By Regions, 2018 (%)

Figure 04. Novartis Ag: Net Sales, 2016-2018 ($Million)

Figure 05. Novartis Ag: Revenue Share By Region, 2018(%)

Figure 06. Novartis Ag: Revenue Share By Segment, 2018 (%)

Figure 07. Roche: Net Sales, 2016-2018 ($Million)

Figure 08. Roche: Revenue Share By Segment, 2018 (%)

Figure 09. Roche: Revenue Share By Geography, 2018 (%)

Figure 10. Ipsen: Net Sales, 2016-2018 ($Million)

Figure 11. Ipsen: Revenue Share By Segment, 2018 (%)

Figure 12. Ipsen: Revenue Share By Geography, 2018 (%)

Figure 13. Ferring Bv.: Net Sales, 2016-2018 ($Million)

Figure 14. Ferring Bv.: Revenue Share By Region, 2018(%)

Figure 15. Roche: Revenue Share By Segment, 2018 (%)